Gilead Urged To Scale-Up of Low-Cost PrEP

-

TAG Welcomes HHS Lawsuit Against Gilead; Urges Dramatic Scale-Up of Low-Cost PrEP


November 11, 2019 – Treatment Action Group (TAG) welcomes the U.S. Department of Health and Human Services (HHS) pursuit of a lawsuit against Gilead Sciences, Inc., the manufacturer of Truvada and Descovy, the only two FDA-approved pills for pre-exposure prophlyaxis (PrEP) to prevent HIV. The suit is the result of months of pressure by activists who have rightly asserted that tenofovir-based PrEP research was underwritten by U.S. taxpayers, many of whom remain shut-out from accessing  PrEP due to financial barriers arising directly from the corporate price gouging.
For years, the drugmaker Gilead has profited off of taxpayer funded research by charging excessive prices for PrEP. Gilead’s high pricing has limited the scope of initiatives to end the HIV epidemic—particularly among low-income communities and communities of color. While TAG and allies call for a dramatic overhaul of the current U.S. patent system, in the meantime, TAG urges the U.S. government to capitalize on this opportunity to hold Gilead accountable for its profiteering and invest any financial compensation in strategies to scale up PrEP to achieve the vision of ending the HIV epidemic in the U.S.
"Ultimately, this must be about immediate and dramatically scaled up access to PrEP for the most marginalized communities in America. For months, advocates have called on the US government to vigorously defend taxpayer investments in tenofovir-based PrEP research; this lawsuit sets the stage for Gilead to be held accountable for billions in unearned revenue,” said Jeremiah Johnson, Director of the HIV Project at TAG. He adds, “Gilead's price gouging has created enormous barriers to access for those most in need of this essential HIV prevention technology; any damages awarded to the government must be fully invested in community-led PrEP navigation programs and other initiatives to increase awareness and utilization."
###
About TAG: Treatment Action Group (TAG) is an independent, activist and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for HIV, tuberculosis, and hepatitis C virus.
--
Suraj Madoori
U.S. and Global Health Policy Director
Treatment Action Group
mobile: +1.917.530.5996


Treatment Action Group 
90 Broad St, Suite 2503
New York, NY 10004 USA

Comments

Post a Comment

Popular posts from this blog

Herpes Simplex Virus ( Cold Sores)

-
Image
What are the symptoms, & how is it diagnosed? The symptoms of herpes depends on the site of disease: Oral herpes (cold sores): Sores around the mouth and nostrils. They may itch or be painful. They might look like the sore in this picture: Genital herpes: Sores on the penis in males or near or in the vagina in women. Genital herpes can also cause sores near the anus, including the area between the anus and the genitals (the perineum). Sometimes, genital herpes can cause pain when urinating or defecation. They might look like the sores in this picture: How is herpes diagnosed? Oral and genital herpes are well-known diseases. Most doctors and other health-care providers know herpes when they see it. In turn, both types of herpes can often be diagnosed—and treatment recommended— simply by examining the sores. However, guidelines published by the Centers for Disease Control and Prevention (CDC) recommends that mouth sores in particular be confirmed by laboratory testi...
Read more

Hacked To Death: Kawere Fahad 21 Years Dies From His Wounds

-
Image
Driven, young, restless and focused begins to describe Kawere Fahad 21 years.  Rest In Peace! Wakiso District, in the Central Region of Uganda is very important to Uganda as DC is to USA or Buckingham is to UK. This area has the biggest number of schools per land size, the oldest Basilica in Africa, real estate hub and is the dormitory District for many urbanites in Uganda.  It is in this area that one finds such suburbs like Kayunga and Nansana. These suburbs never go to sleep!   One would expect that this metropolitan profile puts it at a place where murder cases are investigated and deterred by police and communities. And that assailants are stopped in their tracks before they delivered a deeply bruising or fatal blow. But this was not the case for Fahad Kawere. KGN has learnt that Fahad and a first batch of friends had a meeting which went up to around 2:30 am (1st August 2019). After the meeting, Fahad got a message and told this...
Read more

Zimbabwean HIV Positive Feminist Martha Tholanah Wins 2015 David Kato Vision & Voice Award

-
Renowned Ugandan activist Frank Mugisha will present Martha Tholanah with the award on stage at the prestigious Teddy Awards ceremony in Berlin  this Friday . 11 February 2015  [Berlin]  – The David Kato Vision & Voice Award (DKVVA) is proud to announce that the 2015 award will go to HIV Positive activist Martha Tholanah from Zimbabwe. Martha risks her life everyday to support lesbian, gay, bisexual, transgender, and intersex (LGBTI) people across the country. Her activism is a powerful example of a straight ally standing in solidarity with LGBTI people despite threats to her own safety and security. Martha also demonstrates extraordinary leadership on behalf of other marginalized communities, fighting for women’s rights, disability rights and sex worker rights both locally and internationally. She will receive the award on stage  this Friday , at the prestigious Teddy Awards ceremony which is part of the Berlin International Film Festiva...
Read more